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Congenital hemangiopericytoma
Hemangiopericytoma is a rare malignant vascular tumor that usually occurs in adults. The occurrence of
these tumors in infants, known as congenital or infantile hemangiopericytoma, is even rarer and their behavior
may be more benign than the adult type. We describe a 1-day-old female neonate with congenital
hemangiopericytoma, presenting with a right inguinal mass at birth. At the time of surgery, lymphangio-
ma was suspected because of its appearance, fluid-filled multicystic content, and the high incidence of this
disease in pediatric patients. Tumor excision was performed and hemangiopericytoma was diagnosed by
histology. There was no tumor recurrence during 12 months of follow-up. [J Formos Med Assoc 2006;105(3):
247–251]
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Hemangiopericytoma is an uncommon vascular
tumor that was first described by Stout and Mur-
ray in 1942.1 Only 10% of cases occur in children
under the age of 15 years.2 Kauffman and Stout
differentiated the congenital or infantile form of
hemangiopericytoma from the adult form based
on the more benign character of the tumor in chil-
dren who are < 1 year old.3 It comprises one-third
of cases in children. The incidence is higher in
boys than in girls.3 Most cases of infantile heman-
giopericytoma have been reported in Western
countries.1–3 Only two patients younger than 1
month have been reported in Eastern countries,
with one in Japan and the other in India.4,5 This is
the first case of congenital hemangiopericytoma
reported in Taiwan.
Case Report
A 1-day-old female neonate, weighing 3300 g,
was born to a 32-year-old, gravida 1, para 0, mother
at 39 weeks’ gestation. There was no consanguini-
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ty or hereditary disease found in the family. The
pregnancy and delivery were normal. The neonate
was admitted to the neonatal ward because of a
right-sided inguinal mass noted at birth.
On admission, physical examination revealed
generally normal findings except for a 4 × 3 cm
elastic and firm mass with purplish discoloration
over the right inguinal area (Figure 1). Ultrasono-
graphic examination of the tumor revealed a
fluid-filled multicystic mass. Magnetic resonance
imaging (MRI) of the pelvis showed a 4 × 4.2 × 4.7
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Figure 1.
A 4 × 3 cm
mass with
discoloration
in the right
inguinal area
noted just after
birth in a
neonate.
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seen within the tumor. Section margins were not
identified because of tumor fragmentation. Mito-
sis was extremely rare. Serial special stains were
performed for further diagnosis. Silver stain
showed a delicate reticulum network around in-
dividual neoplastic cells (Figure 2B). Vimentin
stain was strongly positive, and neuron-specific
enolase stain was weakly positive. Smooth muscle
actin and CD34 stain were strong in the cytoplasm
in perivascular neoplastic cells, but showed taper-
ing reactivity in neoplastic cells further from the
vessels. Cytokeratin, S-100 protein, desmin,
myogenin, CD31, and CD117 were negative. Mor-
phologic and immunohistochemical results con-
firmed the diagnosis of infantile hemangioperi-
cytoma. Because residual tumor was found after
incomplete resection, the stage of the tumor in
this patient was classified as Group III according
to the Intergroup Rhabdomyosarcoma Study
(IRS).7 Chemotherapy was considered but with-
held after discussion with the family and the
pediatric oncologist regarding the risk of chemo-
therapy in neonates. The postoperative course was
smooth and the patient was discharged at 18 days
of age.
Over 12-months of follow-up at our outpatient
clinic, physical examinations revealed no sign of
local progression of the residual tumor. MRI per-
formed at 2 months of age showed residual nodu-
lar lesions with abnormal enhancement. Small
cm multiloculated, multicystic lesion at the right
lower anterior abdominal wall and right inguinal
subcutaneous area without remarkable intra-
abdominal extension. Moderate septal enhance-
ment after contrast medium injection and previ-
ous hemorrhage were also noted. Laboratory data
were normal, including complete blood cell count,
coagulopathy profile, and serum levels of `-human
chorionic gonadotropin and _-fetoprotein. Because
lymphangioma is one of the most common vascu-
lar tumors in pediatric patients,6 this disease was
highly suspected before surgical exploration. After
considering that rapid enlargement of lymphan-
gioma can occur with infection or hemorrhage,
surgery was performed at 10 days of age, which
revealed a 4 × 3 cm reddish-yellow encapsulated
mass with central hemorrhage. The tumor was not
totally removed due to its encapsulation with fem-
oral vessels. Frozen section during the operation
revealed round-to-oval hyperchromatic nuclei in
the tumor cells.
Pathology showed an ill-defined infiltrating
hypercellular tumor. The tumor cells were round-
to-oval pleomorphic neoplastic cells with indis-
tinct cellular border and nucleoli, arranged in sol-
id sheets without any particular growth pattern
such as storiform or fascicular arrangements (Fig-
ure 2A). Many large vessels and capillaries were
noted within the tumor. Focal necrosis, fragmen-
tation, and old and fresh hemorrhage were also
Figure 2. (A) Hematoxylin and eosin stain (× 600) of the resected tumor shows round-to-oval pleomorphic neoplastic cells with indistinct
cellular border and nucleoli arranged in solid sheets without any particular growth pattern. Many large vessels and capillaries are noted
within the tumor. Mitosis is extremely rare, but focal tumor necrosis is found. (B) Reticulum stain (original magnification × 60) shows
a delicate reticulum network around individual neoplastic cells.
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focal areas of abnormal high signal intensity were
found in both the right inguinal subcutaneous re-
gion and the right femoral canal. No definite focal
destructive bone lesion was noted.
Discussion
This is the first case of congenital hemangioperi-
cytoma reported in Taiwan. Hemangiopericytoma
has a wide variation of presentation, including tu-
mor size and growth, clinical manifestations, and
malignant potential.8 The majority of these tumors
in adults tend to be highly malignant. Congenital
hemangiopericytoma has been considered to be
a distinct entity from the adult form of the disease.
Most infantile hemangiopericytomas are benign.
Good response to chemotherapy, spontaneous
regression, and no recurrence even with residual
tumor have been reported in the infantile type.9–12
However, children > 1 year old have a similar ma-
lignant disease course to adults. Increased age is
a risk factor associated with a more malignant
clinical course.2,8 The mechanism responsible for
this difference with age is not well understood.12
One possibility for the distinctive benign course
of infantile hemangiopericytoma may relate to its
maturation ability.8,12
The diagnostic mainstay of infantile hemangi-
opericytoma is biopsy and histologic confirmation,
while imaging studies and laboratory examina-
tions are seldom helpful.13 Plain radiographs, an-
giograms, computed tomography and MRI are
all nonspecific for infantile hemangiopericytoma,
but the information obtained from these exami-
nations may be useful in preoperative planning.
Lymphangioma is the second most common be-
nign vascular tumor in children.6 As in our patient,
the similarity of clinical manifestations and the
imaging studies of infantile hemangiopericytoma
may lead to a misdiagnosis as lymphangioma,
which is a much more common disease in neo-
nates. Pathologic and immunohistochemical exam-
inations are crucial for a definite diagnosis of hem-
angiopericytoma. Hemangiopericytoma is usually
a firm, rubbery and painless tumor.13 It is com-
posed mainly of a kind of perivascular cell called a
pericyte. Pericyte tumor cells can be oval or round,
and are arranged homogeneously around thin-
walled endothelium-lined vascular channels.13,14
The pericytes can interact with endothelial cells
by many long cytoplasmic processes to form inter-
digitating contacts. They may influence the matu-
ration, remodeling, maintenance and permeabili-
ty of the vascular system.13,14 They can also be con-
tractile like smooth muscle.15 Since the tumor ori-
ginates from perivascular cells, it may occur any-
where in the body where capillaries exist. Approx-
imately 30–50% of infantile hemangiopericyto-
mas occur in the extremities, especially the lower
extremities.12,13,16 Microscopically, infantile hem-
angiopericytoma is similar to the adult type, but
the lesion in infants is usually located in subcuta-
neous tissues, while the adult type is often located
in deeper structures.2,12–14 It is multilobulated, of-
ten with distinct intravascular and perivascular
satellite nodules outside the main tumor mass,
and endovascular growth is frequent.14 Silver stain
is usually positive, and stain for _-smooth muscle
actin is positive in varying degrees.13 The tumor
cells also stain positive to vimentin, which indi-
cates the mesenchymal origin of the lesion.13,16
It is extremely difficult to predict the malignant
potential of such tumors in infants. Although
factors such as hypercellularity, increased mitotic
activity, anaplasia, necrosis, and hemorrhage have
been reported to be associated with malignant be-
havior in adult hemangiopericytoma, no such as-
sociations have been found in the infantile type.14,17
Infantile hemangiopericytoma may have more mi-
totic figures and focal necrosis than the adult type,
but is generally benign in its clinical course.13 Since
there are no specific histologic criteria to differen-
tiate whether these tumors are benign or malignant,
classification has often been based on clinical be-
havior.12,18,19 Patients may be classified according
to the criteria of the IRS as follows: Group I in-
cludes completely excised tumors; Group II in-
cludes those patients whose tumors are grossly
resected with either microscopic evidence of re-
sidual disease at the primary site (Group IIa), re-
gional lymph node involvement that is complete-
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ly resected (Group IIb), or regional lymph node
involvement that is grossly removed with evidence
of microscopic residual tumor (Group IIc); Group
III includes patients with gross residual disease
after incomplete resection or biopsy; and Group
IV comprises patients with metastases at onset.7
The clinical behavior of the tumor in our patient
appeared to fit IRS Group III, since residual tumor
was noted after incomplete resection.
The ideal therapy for infantile hemangioperi-
cytoma is to enhance long-term survival without
injury to other growing organs.4,12 The most com-
mon management is wide surgical excision when
the tumor is resectable.13,19 Preoperative vascular
embolization or ligation has been used for large
hemangiopericytoma with life-threatening hemor-
rhage.20 Where total excision is not possible or, in
cases with recurrence after surgery, chemother-
apy before or after further operation is usually pre-
ferred.11,13,15 Chemotherapy agents including vin-
cristine, doxorubicin, actinomycin, and cyclophos-
phamide are commonly used singly or in combi-
nation in various regimens. del Rosario and Saleh
reported a 2-month-old boy with unresectable
nuchal hemangiopericytoma with lung metasta-
sis.8 The tumor regressed and was resected after
combination chemotherapy with vincristine, dox-
orubicin and cyclophosphamide. This treatment
also resulted in resolution of the metastatic lesion.
Most reported cases who received chemotherapy
were diagnosed after the neonatal period. In our
patient, total excision of the tumor was impossi-
ble due to its encapsulation with femoral vessels.
Due to the residual tumor and lack of definite his-
tologic criteria to predict malignant behavior,
chemotherapy was considered but withheld after
discussion with the family and the pediatric onco-
logist because of concerns regarding chemotherapy-
associated complications in neonates. There have
been few case reports of a malignant course such
as metastasis or recurrence in infantile hemangi-
opericytoma,10,15,21,22 while the metastatic rate of
the adult type was as high as 56%.13 We regularly
followed up this patient at the outpatient clinic
for 1 year after the surgery, and no recurrence or
metastasis was found. However, given the poten-
tial for recurrence and metastasis, long-term fol-
low-up is essential for congenital hemangioperi-
cytoma presenting in the neonatal period with in-
complete excision of the tumor.10,15,21,22 The role
of radiation therapy in infantile hemangiopericy-
toma is controversial.8
In conclusion, infantile hemangiopericytoma
is a rare vascular tumor that should be considered
in the differential diagnosis of vascular malform-
ations in pediatric patients. Diagnosis of heman-
giopericytoma requires biopsy and histologic
confirmation. Wide surgical excision followed
by close observation should be the treatment of
choice. Chemotherapy may be considered for
unresectable lesions or cases with recurrence and
metastasis after the neonatal period. Long-term
follow-up is mandatory to monitor the clinical
behavior of the tumor after resection.
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